Pathway Genomics Stock

Founded in 2008, Pathway Genomics with the aim of providing users with the most validated and personalized healthcare information. The company’s CLIA and CAP-accredited clinical laboratory provides physicians and their patients with actionable, precision healthcare information to help improve or maintain health and wellness. Its testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, and drug response for specific medications.